Litigation
at Brussels (BE) Local Division
15 litigation decisions from Brussels (BE) Local Division.
Litigation Decisions
15 cases | Page 1 of 1
Establishment Labs S.A. v.GC Aesthetics ParentCo Limited, Nagor Limited, GC Aesthetics Management Limited, GC Aesthetics (Distribution) Limited, GC Aesthetics (France) SAS, EuroSilicone SAS, GC Aesthetics GmbH, GC Aesthetics Spain, S.L.U., Global Consolidated Aesthetics (UK) Limited, GC Aesthetics Holdings Limited, GC Aesthetics Finance Limited, Romed NV
Infringement Action
Establishment Labs S.A. v.GC Aesthetics ParentCo Limited, Nagor Limited, GC Aesthetics Management Limited, GC Aesthetics (Distribution) Limited, GC Aesthetics (France) SAS, EuroSilicone SAS, GC Aesthetics GmbH, GC Aesthetics Spain, S.L.U., Global Co
This Order II concerns an application under Rule 190 of the Rules of Procedure filed by the GC Aesthetics group of companies in parallel UPC proceedings (infringement action UPC_CFI_1357/2025 and counterclaim for revocation UPC_CFI_629/2025) relating to European Patent EP 3 107 487 B1. The applicants sought an order requiring LABS to produce specific evidence, including sales figures for Motiva SilkSurface implants, physical samples manufactured before the priority date, and various promotional and marketing materials. The Court granted the 'Primary Order' requests (with the exception of request I.c and an adjustment to request I.b), ordering LABS to produce the requested evidence within 21 days, while emphasizing the need to align evidence-gathering requests between parallel UPC and UK proceedings for procedural efficiency and proportionality.
2seventy bio, Inc. v.Johnson & Johnson, Janssen Biotech, Inc., Janssen Pharmaceuticals Inc., Janssen-Cilag International NV, Janssen Pharmaceutica NV, Janssen-Cilag NV, Janssen Biologics B.V., Janssen-Cilag B.V., Janssen-Cilag GmbH, Janssen-Cilag SAS, Janssen-Cilag SpA, Janssen-Cilag A/S, Janssen-Cilag Aktiebolag, Janssen-Cilag Farmaceutica Lda., Legend Biotech Corporation, Legend Biotech USA Inc. , Legend Biotech Ireland Limited, Legend Biotech Belgium BV
Counterclaim for revocation
Establishment Labs S.A. v.GC Aesthetics ParentCo Limited Nagor Limited GC Aesthetics Management Limited GC Aesthetics (Distribution) Limited GC Aesthetics (France) SAS EuroSilicone SAS GC Aesthetics Italy S.R.L. GC Aesthetics GmbH GC Aesthetics Spain, S.L.U. GC Aesthetics GmbH GC Aesthetics Holdings Limited GC Aesthetics Finance Limited Romed NV
Counterclaim for revocation
Establishment Labs S.A. v.GC Aesthetics ParentCo Limited Nagor Limited GC Aesthetics Management Limited GC Aesthetics (Distribution) Limited GC Aesthetics (France) SAS EuroSilicone SAS GC Aesthetics Italy S.R.L. GC Aesthetics GmbH GC Aesthetics Spai
Establishment Labs S.A. (LABS), the proprietor of EP 3 107 487 B1, applied under Rule 263.3 RoP to limit its infringement action by withdrawing the UK designation portion of its claim against several GC Aesthetics defendants. The defendants sought dismissal, declarations of manifest inadmissibility under Rule 361 RoP, immediate cost awards, and prospective restrictions on future UPC claims. The Brussels Local Division granted LABS unconditional leave to limit its claims, held that Defendants 2 and 10 no longer had a legal basis to remain in the infringement proceedings but should stay for cost purposes, granted the defendants leave to limit their counterclaim, and granted leave to appeal.
Establishment Labs S.A. v.GC Aesthetics ParentCo Limited Nagor Limited GC Aesthetics Management Limited GC Aesthetics (Distribution) Limited GC Aesthetics (France) SAS EuroSilicone SAS GC Aesthetics Italy S.R.L. GC Aesthetics GmbH GC Aesthetics Spain, S.L.U. Global Consolidated Aesthetics (UK) Limited GC Aesthetics Holdings Limited GC Aesthetics Finance Limited Romed NV
Counterclaim for revocation
Establishment Labs S.A. v.GC Aesthetics ParentCo Limited Nagor Limited GC Aesthetics Management Limited GC Aesthetics (Distribution) Limited GC Aesthetics (France) SAS EuroSilicone SAS GC Aesthetics Italy S.R.L. GC Aesthetics GmbH GC Aesthetics Spai
Establishment Labs S.A. (LABS), the proprietor of EP 3 107 487 B1, applied under Rule 263.3 RoP to limit its infringement action by withdrawing the UK designation portion of its claim against several GC Aesthetics defendants. The defendants sought dismissal, declarations of manifest inadmissibility under Rule 361 RoP, immediate cost awards, and prospective restrictions on future UPC claims. The Brussels Local Division granted LABS unconditional leave to limit its claims, held that Defendants 2 and 10 no longer had a legal basis to remain in the infringement proceedings but should stay for cost purposes, granted the defendants leave to limit their counterclaim, and granted leave to appeal.
YEALINK (XIAMEN) NETWORK TECHNOLOGY Co. Ltd. YEALINK (EUROPE) NETWORK TECHNOLOGY BV v.BARCO NV
Generic Order
Simmons & Simmons LLP GENENTECH INC. F. HOFFMANN – LA ROCHE AG v.ORGANON HEIST B.V. NV ORGANON
Access To Case
Simmons & Simmons LLP GENENTECH INC. F. HOFFMANN – LA ROCHE AG v.ORGANON HEIST B.V. NV ORGANON
In this legal proceeding before Brussels (BE) Local Division (decision issued on 2026-05-04) under reference UPC_46FFEC8858, Simmons & Simmons LLP GENENTECH INC. F. HOFFMANN – LA ROCHE AG appeared in dispute with ORGANON HEIST B.V. NV ORGANON concerning patent rights and legal remedies.
ESKO-SOFTWARE BV, ESKO-GRAPHICS BV v.IN(K)CONTROL BV
Infringement Action
ESKO-SOFTWARE BV, ESKO-GRAPHICS BV v.IN(K)CONTROL BV
This order concerns an application by the Defendants (Esko-Software BV and Esko-Graphics BV) to change the language of proceedings from Dutch to English in an infringement action brought by In(k)control BV based on European Patent EP3841735. The President of the Court of First Instance addressed whether further submissions beyond those foreseen by R. 323.2 RoP should be considered, and weighed the relevance of English being the language of the patent and the technology field against the particular circumstances of the parties' size and domicile. The order was issued following consultation with the panel of the Local Division Brussels.
GC AESTHETICS PARENTCO LIMITED 2. NAGOR LIMITED 3. GC AESTHETICS MANAGEMENT LIMITED 4. GC AESTHETICS (DISTRIBUTION) LIMITED 5. GC AESTHETICS (France) SAS 6. EUROSILICONE SAS 7. GC AESTHETICS ITALY S.R.L. 8. GC AESTHETICS GmbH 9. GC AESTHETICS SPAIN, S.L.U. 10. GLOBAL CONSOLIDATED AESTHETICS (UK) LIMITED 11. GC AESTHETICS HOLDINGS LIMITED 12. GC AESTHETICS FINANCE LIMITED 13. ROMED N.V. v.ESTABLISHMENT LABS S.A.
Infringement Action
Establishment Labs S.A. v.GC Aesthetics Parentco Limited et al.
Establishment Labs S.A. (LABS), the proprietor of EP 3 107 487 B1, applied under Rule 263.3 RoP to limit its infringement action by withdrawing the UK designation portion of its claim against several GC Aesthetics defendants. The defendants sought dismissal, declarations of manifest inadmissibility under Rule 361 RoP, immediate cost awards, and prospective restrictions on future UPC claims. The Brussels Local Division granted LABS unconditional leave to limit its claims, held that Defendants 2 and 10 no longer had a legal basis to remain in the infringement proceedings but should stay for cost purposes, granted the defendants leave to limit their counterclaim, and granted leave to appeal.
YEALINK (XIAMEN) NETWORK TECHNOLOGY Co. Ltd. YEALINK (EUROPE) NETWORK TECHNOLOGY BV v.BARCO NV
This is an Order of the Court of Appeal concerning an Application for provisional measures under Rule 206 RoP. The Court addressed issues of competence of local divisions, urgency, and interim award of costs in provisional measures proceedings. The Order establishes that Rule 19.5 RoP applies mutatis mutandis to provisional measures proceedings, that there is no hierarchy between the competence grounds in Art. 33(1)(a) and Art. 33(1)(b) UPCA, and that competence assessment should be cursory rather than comprehensive. The Court also held that an interim award of costs up to half of the applicable ceiling is generally appropriate in provisional measures proceedings.
Facing a similar IP matter?
Arctic Invent is a specialist IP firm with deep litigation expertise across India, EU, US, and UK. Our team uses data-driven strategy to build stronger cases.